Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTSH-assisted radioiodine vs thyroid hormone withdrawal for metastatic differentiated thyroid cancer
ChiCTR2500112654Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Nov 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of thyrotropin alfa in well-differentiated thyroid cancer (WDTC) (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Objective remission rate, CT indicators and 1 more. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
thyrotropin alfa
03
Conditions
well-differentiated thyroid cancer (WDTC)
Beyond the preview
Go deeper on ChiCTR2500112654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112654.